Cargando…
Expression Status and Prognostic Value of m(6)A RNA Methylation Regulators in Lung Adenocarcinoma
N(6)-methyladenosine (m(6)A) RNA modification is the most abundant modification method in mRNA, and it plays an important role in the occurrence and development of many cancers. This paper mainly discusses the role of m(6)A RNA methylation regulators in lung adenocarcinoma (LUAD) to identify novel p...
Autores principales: | Li, Xiuhong, Feng, Zian, Wang, Rui, Hu, Jie, He, Xiaodong, Shen, Zuojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306618/ https://www.ncbi.nlm.nih.gov/pubmed/34206803 http://dx.doi.org/10.3390/life11070619 |
Ejemplares similares
-
Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022) -
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019) -
Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma
por: Xu, Bin, et al.
Publicado: (2018) -
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020) -
Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR‐103b/877‐5p/29c‐5p as diagnostic biomarkers for early lung adenocarcinoma
por: Wu, Jing, et al.
Publicado: (2022)